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PropofolThis is part of a continuing patch-clamp study exploringmolecular actions of anesthetics and systematically var-
ied related substances on 5-HT3A receptors as prototypes of ligand-gated ion channels. Speciﬁcally, n-alkanols,
related to but simpler in structure than propofol, were studied to explore the complex actions of this leading in-
travenous anesthetic.
Outside-out patches excised from HEK 293 cells heterologously expressing human 5-HT3A receptors were
superfusedwith even-numbered n-alkanols (ethanol through n-tetradecanol) of different concentrations. Fast solu-
tion exchange for varying durations allowed separation of drug actions by their kinetics.
Comparedwith propofol the electrophysiological responses to n-alkanols were not much simpler. n-Alkanols
produced fast and slow inhibition or potentiation of current amplitudes, and acceleration of current rise and
decay time constants, depending on exposure time, concentration, and chain-length of the drug. Inhibition dom-
inated, characterized by fast and slow processes with time constants separated by two orders of magnitude
which were similar for different n-alkanols and for propofol. Absolute interaction energies for ethanol to n-
dodecanol (relative to xenon) ranged from−10.8 to−37.3 kJ mol−1.
No two n-alkanols act completely alike. Potency increases with chain length (until cutoff) mainly because of
methylene groups interacting with protein sites rather than because of their tendency to escape from the aque-
ous phase. Similar wash-in time constants for n-alkanols and propofol suggest similar mechanisms, dominated
by the kinetics of conformational state changes rather than by binding reactions.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Why is ethanol in contrast to propofol such a poor general anesthet-
ic, although both drugs share several physicochemical characteristics?
Though known to mankind for millennia ethanol has never made it
into routine clinical practice, while propofol has become the most
widely used clinical intravenous anesthetic since its introduction less
than ﬁfty years ago.
This and future papers are to explore the differences between the
intravenous anesthetic propofol and inhalation anesthetics while trying
to understand at the same timewhichmolecular characteristics of alco-
hols –which in several ways have physicochemical properties interme-
diate between these drug classes –may prevent them from being good
general anesthetics. Although not differing much in their lipophilicity,
intravenous anesthetics appear to have generally greater hypnotic
potency than inhaled anesthetics. They act also more potently on iongy and Intensive CareMedicine,
3127 Bonn, Germany. Tel.:+49
ker), stefan-witten@web.de
i-bonn.de (B.W. Urban).channels, of which the ligand-gated ion channels are generally more
susceptible than voltage-gated ion channels [1].
There is agreement in the anesthetic literature that there is disagree-
ment as to which ion channels are relevant to general anesthesia, de-
pending on which prominent author you read. Any but superﬁcial
consideration of what deﬁnes general anesthesia will result in reluc-
tance to state exclusively which ion channels are relevant to general an-
esthesia. Particularly also the failure of the drug industry to proﬁt from
the molecular genetic approach to synthesizing better and speciﬁc
drugs has led to a new appreciation of the importance of so-called
“dirty drugs”, acting at many receptors. General anesthetics are dirty
drugs par excellence, which have been shown already to act on a num-
ber of different receptors.
This is part of a systematic study exploring molecular actions of
anesthetics and anesthetic-like substances on membrane proteins [1],
here on 5-HT3A receptors as prototypes of ligand-gated ion channels.
In contrast to other ligand-gated ion channels, the homopentameric
5-HT3A receptor forms functional ion channels, which simpliﬁes subse-
quent kinetic analyses. It also has a slow onset kinetic thus allowing
the resolution of fast wash-in kinetics of anesthetic agents which
would be difﬁcult to detect for faster activating ligand-gated ion chan-
nels. Kinetic models emerging from systematic studies on 5-HT3A
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gated ion channels.
In a series of studies, both published [2–5] and underway, anesthetic
target sites are characterized and mapped by a systematic variation of
anesthetic-related drugs serving as probes, in contrast to the comple-
mentary approach of site-directed mutagenesis.
These and similar studies of voltage-gated sodium and potassium
channels [6,7] as well as other proteins [8–10] suggest that several but
weak interactions with many proteins are characteristic of general
anesthetic action, involving both polar and nonpolar, both speciﬁc and
nonspeciﬁc interactions [1]. The drug with the weaker polar group ap-
pears to be the better anesthetic: thus propofol (its phenolic hydroxyl
group shielded by two isopropyl neighbors on either side) rather than
phenol, and diethyl ether rather than ethanol (the ether oxygen being
less polar than a hydroxyl group) have been in clinical use [11]. A
hypothesis based on the homeostasis of lipophilic substances has been
proposed as a mechanism of anesthesia that would allow many anes-
thetic actions to occur simultaneously, yet not result in physiological
chaos [11].
Regarding propofol we found that it was considerably less potent
than other intravenous anesthetics in its actions, yet the actions of
propofol and structurally closely related phenol derivatives were com-
plex, affecting both the amplitudes and the kinetics of 5-HT induced
currents [2–4]. The combination of patch-clamp of excised outside-out
patches with a fast solution exchange system allowed the kinetic
separation of different anesthetic actions on 5-HT3A receptors as well
as the examination of their current kinetics, leading to the identiﬁcation
of at least two separate actions with time constants in the tens of milli-
seconds range and in the seconds range, respectively. Whereas overall
actions on 5-HT3A receptors were inhibitory, an enhancing component
of anesthetic action could be detected in some phenol derivatives. This
component is normally masked by an overall suppression in equilibri-
um conditions. Underlyingmechanisms appeared to involve the pheno-
lic hydroxyl group, hydrophobic interactions, and steric restrictions [4].
In this paper, n-alkanols are investigated because as simple acyclic
alcohols they are related to propofol but are less complex in structure.
Thus they sharewith propofol and similar phenol derivatives a common
structure consisting of a hydrophobic moiety and a polar hydroxyl
group (–OH). They differ from propofol and are simpler in that they
do not possess branched hydrocarbons and, not being aromatic, lack
delocalized electrons. The balance of hydrophobic and polar interac-
tions can be shifted in thedirection of hydrophobic properties becoming
increasingly more dominant when the chain length of the n-alkanol is
increased, without the structure of the n-alkanol changing. By contrast,
in the series of alkylated phenols, the structure does change as the
hydroxyl groups of 2-isopropylphenol and of propofol are surrounded
by one or two isopropyl groups, respectively; this may compromise
the accessibility of the hydroxyl group compared with n-alkanols [4].
Steric interactions and/ormolecular size have been suggested as po-
tential causes preventing propofol from having the current-enhancing
effects on 5-HT3A receptor channels described above [4]. n-Alkanols
may be suitable probes to distinguish between these possibilities as
they have been reported to also cause potentiation of 5-HT induced
currents, with a molecular cutoff occurring around n-hexanol [12,13].
Using our previous experimental approach the aims of this study
were (i) to identify separate components of action of n-alkanols and
to test whether the greater structural simplicity of n-alkanols is
reﬂected in less complex current responses, (ii) to quantitate the contri-
butions of polar and non-polar groups to the interaction energy and to
test whether physicochemical functional groups can be correlated
with electrophysiological action, (iii) to compare the actions of
n-alkanols with those of propofol and phenol derivatives, and (iv) to
provide the basis for future comparisons with ongoing studies where
the balance between hydrophobic and polar contributions is shifted,
alternatively, by changing the polar groups, resulting in structurally
even simpler inhalation anesthetics such asdialkyl-ethers andn-alkanes.2. Materials and methods
2.1. Cell culture
Transfected human embryonic kidney 293 cells stably expressing
human 5-HT3A receptors [14] were grown as mono-layers on culture
plates (NUNC, Wiesbaden, Germany) in DMEMNutrient Mix F12 medi-
um containing 10% heat-inactivated fetal calf serum, penicillin
(100 IU ml−1), streptomycin (100 μg ml−1), geneticine (0.75 μg ml−1)
and glutamine (292 μg ml−1). The cells were cultured at 37 °C in a
humidiﬁed atmosphere (5% CO2) and afterwards transferred to 35 mm
Petri dishes (NUNC). The cells were ready for electrophysiological
experiments 7-11 days after transfer.
2.2. Drugs and solutions
Ethanol, n-butanol and n-hexanol were obtained from Merck
(Darmstadt, Germany), n-octanol from Fluka Chemie AG (Buchs,
Switzerland), n-decanol, n-dodecanol and n-tetradecanol from Sigma-
Aldrich (Munich, Germany). 5-HT (serotonin creatinine sulfate com-
plex) was obtained from Sigma (Munich, Germany). 30 μM (unless
speciﬁed otherwise) 5-HT solutions were prepared daily from 25 mM
aqueous stocks (stored at−20 °C). Drug solutions for ethanol, n-buta-
nol, n-hexanol and n-octanol were prepared daily by dissolving the
pure substance in extracellular solution.When n-decanol was prepared
in this manner, it had to be stirred for at least 48 h to ensure that it had
completely dissolved. n-Decanol was also prepared from ethanolic
stock (10mM)bydilution, resulting in amaximal ethanol concentration
of 4.3 mM. Both ways of preparing n-decanol solutions resulted in
IC50steady-state values for current inhibition that were not signiﬁcantly dif-
ferent. n-Dodecanol and n-tetradecanol solutions were only prepared
from ethanolic stock solutions (10mM), resulting in a maximal ethanol
concentration of 1.7 mM.
2.3. Electrophysiology
Currents through the 5-HT3A receptor were measured in excised
outside-out patches with the patch-clamp technique. Before starting
patch-clamp recordings, the culture mediumwas replaced by ‘extracel-
lular’ solution of the following composition (mM): NaCl 150; KC1 5.6;
CaCl2 1.8; MgCI2 1.0; HEPES 10; D-glucose 20; and pH 7.4. The extracel-
lular solution used for superfusion contained no D-glucose. Patch
pipettes with resistances of 2–6 MΩwere manufactured from borosili-
cate glass capillaries (Kwik-FilTM, World Precision Instruments, U.S.A.)
using a pipette puller (List L/M-3P-A) and ﬁlled with intracellular
solution composed of (mM): KC1 140, EGTA 10, MgCl2 5, HEPES 10,
and pH 7.4. Experiments were performed at room temperature
(18–22 °C). For currentmeasurementswe used a patch-clamp ampliﬁer
(EPC-7, List Electronic, Darmstadt, Germany) in combination with an
external low pass ﬁlter set at 1 kHz (either Frequency Devices, MA,
U.S.A. or LPBF-48DG, NPI Electronic, Tamm, Germany). Data were
digitally recorded at a sampling rate of 2 kHz with a Digidata 1200
(Axon Instruments, Foster City, CA, U.S.A.) interface and protocols of
the current responses were recorded with Clampex 6 software
(Axon). 500 ms before 5-HT exposure, the membrane potential was
hyperpolarized from 0 to−100 mV.
2.4. Drug application modes
The drug application system was a multi-tube superfusion system
(RSC 200, Biologic, France) with a ﬂow rate of 1–2 ml/min. It contained
a rotating head equipped with ﬁve or nine separate glass capillaries as
perfusion pipets, allowing the application of ﬁve (5-tube conﬁguration)
or nine (9-tube conﬁguration) different solutions. With the RSC 200
superfusion system, maximally two (never three or more) solutions
1526 A.-M. Decker et al. / Biochimica et Biophysica Acta 1848 (2015) 1524–1535ﬂow simultaneously at any one time (only one solution ﬂows onto the
patch and in its immediate vicinity).
Its stepping motor was set to complete a rotation to a new position
within 32 ms. Considering that it takes currents induced by 30 μM
5-HT about 20 ms to reach their peak, the fastest wash-in data point
that can be reported by the system is 20 ms when 5-HT and the drug
are applied simultaneously, and 52 ms (i.e. 32 ms + 20 ms) when the
drug and 5-HT are applied successively. In order to minimize loss of
lipophilic drugs, all parts of the superfusion system were made of inert
materials like Teﬂon® and glass, except for a short piece of tubing and
valve provided with the superfusion system (RSC 200, Biologic, France)
and the initial drip chamber (Intraﬁx SafeSet, B. Braun Melsungen AG,
Germany) serving as reservoir [3].
The reproducible positioning of the patch in relation to the perfusion
pipet is critical. It is veriﬁed during an experiment by checking many
parameters of the kinetic responses of the elicited currents (delay of
response, number of rise time constants and decay time constants, inho-
mogeneities in the current responses). When an outside-out patch was
excised from a smooth, angularly shaped cell, extracellular solutionwas
applied for a period of 60 s before starting the measurements. Between
each application the patch was ‘washed out’with extracellular solution.
Because of the typical slow recovery of 5-HT3A receptors from desensi-
tization following 5-HT exposure, a minimum of one minute was
allowed to elapse before the next current was elicited. If the duration of
the application of the n-alkanol exceeded one minute, the same amount
of time was allowed for wash-out before another current was recorded.
Each experimental run with the 5-tube conﬁguration consisted of a
total of three control currents (30 μM 5-HT only) and three currents
under drug application (30 μM 5-HT and drug), alternating between
control and drug. To compensate for rundown effects, the three currents
under control conditions and the three currents during drug exposure
were averaged, respectively, before further analysis (τrundown =
550 ± 230 s, n = 6 patches under control conditions only, with no
drug exposure, each patch lasting at least three time constants). In the
case of n-tetradecanol (4 min wash-in), it was not always possible
to have three successive runs each of control and drug application
(requiring a patch lifetime of at least 24 min); therefore, to compensate
for rundown effects the controls bracketing a drug application were
averaged before further analysis.
The 9-tube conﬁguration allowed the application of three different
drug concentrations to the same patch. An experimental run always
followed the sequence: control, drug (concentration 1), control,
drug (concentration 2), control, drug (concentration 3), control, drug
(concentration 1), … and was repeated as long as the patch lasted,
always starting with the lowest drug concentration. To compensate
for rundown effects, the controls bracketing a drug application were
averaged before further analysis.
When two current traces resulting from a drug being applied in two
different modes were compared in the same ﬁgure (Fig. 1), they were
corrected for rundown by multiplying the second (drug) trace by the
ratio of the respective control currents. This correction was typically of
the order of 5–10%.
The 9-tube conﬁguration was also used to measure the effect of
n-alkanol on currents elicited by 1, 2 or 30 μM 5-HT, respectively.
In this case, an experimental run in the open-channel application
followed the sequence control (30 μM 5-HT), control (1 μM 5-HT),
n-alkanol + 1 μM 5-HT, control (2 μM 5-HT), n-alkanol + 2 μM 5-HT,
n-alkanol + 30 μM 5-HT, control (30 μM 5-HT), … , and was repeated
as long as the patch lasted.
Three different protocols of drug application were used:
• Steady-state application: continuous exposure to the drug 60 s before
and during the application of 5-HT.
• Wash-in application: similar to steady-state application except that
the 60 s wash-in period is replaced by a wash-in period varying
between 52 ms and 270 s.• Open-channel application: no drug application prior to the 5-HT pulse,
drug application only simultaneously with 5-HT.
2.5. Data analysis and statistics
Analysis was performed with pClamp 8 (Axon, Foster City, CA) and
GraphPad Prism 5 software (GraphPad, CA, USA), which was also used
for the creation of graphics.
Whenever possible, the time courses of 5-HT induced currents were
ﬁtted simultaneously for onset and decay with a biexponential function
(pClamp 8, Axon), yielding the time constants for current onset (τrise)
and current decay (τdecay). The decay of currents from this subtype of
5-HT3A receptor can generally be described by a single time constant
[14]. Rarely did currents have to be ﬁtted separately for the onset or
decay phases, using a single exponential function respectively.
We choose to use the terms τrise (instead of τactivation) for current
onset and τdecay (instead of τdesensitization) for current decay because in
the presence of n-alkanols we can no longer assume that the rising
and decaying phases of the 5-HT evoked current simply reﬂect activa-
tion and desensitization processes modiﬁed directly by the drug.
Instead, other blocking processes, independent of activation and desen-
sitization mechanisms, may contribute to modiﬁed time constants of
the rising and decaying phases, respectively.
The concentration-response curves were ﬁtted by the Hill-Equation
i= [1 / (1+ cn / IC50n )], i is the remaining peak current as fraction of the
maximal (control) current, c is the drug concentration, n is the Hill coef-
ﬁcient, and IC50 is the drug concentration causing half-maximal effect.
Wash-in curves were ﬁtted with a biexponential decay function of
time (t):
I tð Þ ¼ I∞ þ Ffast  1− I∞ð Þ  exp − t =τfast
 
þ 1−Ffast
 
 1− I∞ð Þ  exp − t=τslowð Þ;
ð1Þ
where I (t) is normalized such that I(t= 0) = 1, I∞= I (t→∞), and Ffast
is the fraction that the fast component contributes to the total effect.
Wash-in curves were ﬁtted in two different ways. i) Unrestricted ﬁt
with free parameters: independently varying the parameters I∞, Ffast,
τfast and τslow for each n-alkanol, and ii) restrictedﬁt with shared param-
eters: varying τfast and τslow but keeping them the same for each n-
alkanol, and freely varying the parameters I∞ and Ffast for each n-alkanol.
The free energy of transfer of n-alkanols between the input phase
(gas or aqueous) and the target site(s), Δμθ,CH2, can be obtained as the
slope of a linear regression when the mole-fraction of the n-alkanol is
plotted against the number of methylene groups it contains according
to the formula [15]:
log xROHin;50% ¼
nΔμθ;CH2
RT
þ const: ð2Þ
where
const: ¼ log aROHsite;50% þ
Δμθ;OH þ Δμθ;CH3
 
RT
ð3Þ
xin,50% is the mole fraction of the n-alkanol ROH in the input phase at
which it causes 50% suppression of the peak current; log is the natural
logarithm; n is the number of methylene groups in the n-alkanol; Δμθ
is the standard free energy (or standard chemical potential) of transfer-
ring the respective functional group from the input phase to the site of
anesthetic action; and asite,50% is the corresponding chemical activity at
the site of anesthetic action. The assumption is made that the interac-
tion takes place when the n-alkanol is in equilibrium with its target
site(s) and that the activities at the site of anesthetic action are equal
for all n-alkanols when they cause 50% suppression [15].
50 = 1.1 M )
-10 pA
100ms
control
open-channel
steady-state
50=30 mM)
-200pA
100ms
50 = 1.5 mM)
500ms
-50pA
50 = 70 µM)
500ms
-50pA
a) Ethanol 1 M ( IC
b) Butanol 30 mM (IC c) Hexanol 1 mM (IC
d) Octanol 100 µM (IC e) Decanol 3 µM (IC 50 = 2.5 µM)
100ms
-50pA
50 = 0.83 µM)
-10pA
100ms
f) Dodecanol 1 µM (IC g) Tetradecanol 0.89 µM (IC 50 > 0.89 µM)
200 ms
-20 pA
Fig. 1. Current responses to open-channel and steady-state applications of n-alkanols differ and depend on chain-length. Representative original traces of 5-HT (30 μM)-induced currents
under control conditions and with drug given in either open-channel or steady-state application modes. For any given n-alkanol, open-channel as well as steady-state applications were
recorded at the samen-alkanol concentration (close to the respective IC50steady-state) and from the samepatch as the control current (seeMaterials andmethods). Note that n-tetradecanol at
the highest achievable aqueous concentration caused less than 50% current reduction in the steady-state application.
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gaseous phase and the 5-HT3A receptor target site,Δμθ,drug1−Δμθ,drug2,
at the concentration where the drugs have 50% effect is:
Δμθ;drug1− Δμθ;drug2 ¼ RT  log xdrug1gas; 50%− log xdrug2gas; 50%
 
¼ RT  log Pdrug150

Pdrug250
 
ð4Þ
where xgas, 50 %drug is the mole fraction of the drug at 50% effect and P 50drug is
the corresponding partial pressure of the drug according to the ideal gas
law, and it is assumed that at 50% effect the activities of both substances
are the same at the receptor target site [15].Results are reported as means ± standard deviations (SD). Differ-
ences between single data points were tested for signiﬁcance with
Student's t tests (Microsoft Excel and GraphPad Prism5). Differences
were considered signiﬁcant when p values for the respective test were
less than 0.05. Linear regression ﬁts were performed with GraphPad
Prism5, r2 being the square of the linear correlation-coefﬁcient. IC50
values and their 95% conﬁdence intervals for concentration-response
curves were obtained from curve ﬁts with GraphPad Prism5. The ﬁt
parameters of the wash-in curves, their 95% conﬁdence intervals and
R2 values (quantiﬁes goodness of ﬁt)were also obtainedwith GraphPad
Prism5.
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n-Alkanols by themselves (in the absence of 5-HT) did not induce
any signiﬁcant current responses. For each of the ﬁve n-alkanols
from n-butanol to n-dodecanol any current response was below 3.5%
of the amplitude of the subsequently 5-HT-induced current in the
same patch (4–6 patches and between 12–14 measurements for each
n-alkanol) and thus below the level at which currents could be resolved
reliably.
When 5-HT3A receptor channels in excised outside-out patches
were exposed to n-alkanols, the currents elicited by 5-HT (30 μM)
were reduced when compared to the respective control currents
(Fig. 1). 30 μM 5-HT represents a concentration at which the response
of the 5-HT3A receptor channel is close to maximal; it serves as refer-
ence both with regard to channel functionality as well as for comparing
the actions of many other anesthetics and anesthetic-like substances.
Current traces are shown for n-alkanol concentrations close to their
respective IC50 values for steady-state application (IC50steady-state, see
below). These traces do not always show 50% effect because of experi-
mental variation and the steepness of the concentration-response
curve in this region. As the chain length of the n-alkanol increased, inhi-
bition in the open-channel application became increasingly less such
that n-alkanols longer than n-decanol had no signiﬁcant effect on the
peak current any longer.
The traces in Fig. 1 show clearly that 5-HT induced currents are
inhibited more after 60 s of n-alkanol exposure (steady-state applica-
tion) than after approximately 20 ms (open-channel application). In
order to determine how long it takes for the inhibition by n-alkanols
to be complete, wash-in experiments were conducted in which
5-HT3A receptors were exposed to n-alkanols for durations between
20 ms (open channel application) and 60 s (steady-state application).
However, in order to compare different n-alkanols at equivalent poten-
cies, their IC50steady-state concentrations had to be determined ﬁrst. These
were established by bracketing the IC50steady-state values with concentra-
tions below and above (Fig. 2). Importantly, in most experiments
these three concentrations were applied to the same patch, consider-
ably reducing the number of experiments necessary to achieve statisti-
cal signiﬁcance.
Concentration-response curves for open channel applications are
shifted to higher concentrations compared with those for steady-state
applications (Fig. 2). No attempt was made to bracket IC50open-channel
values for all n-alkanols in the open-channel application since limita-
tions of aqueous solubility prevented theirmeasurements for the higher
n-alkanols.
IC50 values for the two different applicationswere obtained by curve
ﬁtting to the Hill equation (Fig. 2, Table 1). The potencies of n-alkanols
increase with chain length, both for open-channel (until n-decanol)
and for steady-state applications (until n-dodecanol).
These concentration-response curves do not show a monotonic
progression from short-chain to long-chain n-alkanols: they overlap
for ethanol, are separated for n-butanol by a factor greater three, overlap
again for n-hexanol, and only then begin to progressively separate for
longer-chain n-alkanols (Table 1). This suggests several, superimposing
interactions (see Discussion).
The potency for inhibition increases with the chain length of the
n-alkanol, each additional methylene group increasing potency by a
factor of 5.1 (from ethanol to n-decanol, Table 1). The interaction
energy responsible for this increase can be estimated from the free
energy, Δμθ,CH2, resulting when a methylene group is transferred
between the aqueous phase and the target site(s). Δμθ,CH2 can be
obtained as the slope of a linear regression when the mole-fraction of
the n-alkanol is plotted against the number of its methylene groups
(see Eqs. (2) and (3) in Materials and methods). When the free energy
is calculated using the experimental IC50steady-state values, it contains both
terms for the n-alkanol interacting with water (aqueous solution from
which it is applied) and with the sites of the anesthetic target(see Eq. (3) in Materials and methods). By considering n-alkanols in
the gas phase instead of in aqueous solution, it becomes possible to
obtain a free energy term that reﬂects only the interaction with the
anesthetic target. This involves the assumption that n-alkanols do not
interact with each other in the gaseous phase (which would be true at
low concentrations). The partial gas pressure, P50, in equilibrium with
the aqueous IC50 can be calculated from the IC50 by using the water/
gas partition coefﬁcients of Table 2. The reciprocal of the P50 thus
reﬂects absolute rather than relative (to the aqueous phase) potency.
When the mole-fraction of the n-alkanol in the gas phase is plotted
against the number of methylene groups it contains, the resulting slope
yields a free energy change per methylene group of −3.27 kJ mol−1
(Fig. 3), in contrast to−3.97 kJ mol−1 when the mole-fraction of the
n-alkanol is plotted in the aqueous phase instead. Whereas the former
free energy value should reﬂect exclusively the interaction with the
anesthetic site of action, the latter free energy value also contains
contributions from n-alkanols interacting with water.
Apart from n-alkanols suppressing the peak amplitudes of 5-HT
induced currents, they also affected their kinetics, which could be re-
solved in our excised patch conﬁguration. The time constants of current
onset (τrise) and current decay (τdecay) for 5-HT (30 μM) induced
currents were in line with those expected for outside-out patches [19].
Relative values of the time constants at n-alkanol concentrations close
to the IC50 (open-channel and steady-state application) are shown in
Fig. 4. Both current onset as well as current decay is generally accelerated
by n-alkanols.
Loss of activity and cutoff may simply reﬂect a drug not reaching its
site of action. There are several reports that long-chain n-alkanols may
take time to reach their full effect. Uptake of n-alkanol by lipid bilayers
sometimes required 15 min to attain complete equilibrium [20]. Exper-
iments with long-chain n-alkanols at various concentrations of lobster
nerve membrane vesicles showed that the inhibitory effect appeared
to depend somewhat on the membrane lipid concentrations of the
preparation [21]. Size-dependence of wash-in time constants had
been reported for the inhibition of sodium currents and of potassium
currents in squid giant axons where the axolemma membrane is
surrounded by several layers of Schwann cells [22].
If anesthetic protein sites are in chemical equilibrium with other
lipophilic phases, e.g. within lipid bilayers or other proteins with lipo-
philic or hydrophobic domains, then ﬁlling these would delay reaching
an equilibrium concentration. These problems should be minimized by
using an excised outside-out membrane preparation in conjunction
with a fast solution exchange system delivering a continuous large
ﬂow of undepleted n-alkanol solution in close vicinity to themembrane
patch.
Concentrations of n-alkanols at or close to their IC50steady-state values
were washed in for different durations, varying between 52 ms and
up to 270 s. The resulting curves averaged over several patches for
each n-alkanol showed biphasic effects which could be well ﬁtted by
biexponential decay (see Fig. 5). There was a fast and a slow effect of
peak current inhibition, except for n-hexanol, where a phase of fast
inhibition was followed by a phase of potentiation that led to a partial
restoration of the peak current.
Except for n-dodecanol, the fast effect was more or less complete
before 52 ms (the fastest wash-in time that could be recorded, see
Materials and methods), implying that the fast time constant cannot
be much slower but probably is faster than 52 ms. This was conﬁrmed
by running unrestricted curveﬁts (see Materials and methods) which
produced fast time constants faster than 52 ms for the n-alkanols up
to n-decanol (see free parameters, Table 3). Consistent with the limited
time resolution, inmost of theseﬁts their conﬁdence intervals could not
be determined (Table 3).
Missing conﬁdence intervals could also be a reﬂection of the ﬁtting
procedure containing more free parameters than can be determined
by the data. Free parameters can be reduced by noticing that there is
no clear trend for either the fast or the slow time constants from the
-2 -1 0 1
0
20
40
60
80
100
a) Ethanol
open-channel
steady-state
240 s wash-in
pe
ak
 c
ur
re
n
ts
 
(%
)
-3.5 -2.5 -1.5 -0.5
0
20
40
60
80
100
b) Butanol
pe
ak
 c
ur
re
n
ts
 (%
)
-4 -3 -2 -1
0
20
40
60
80
100
c) Hexanol
-5 -4 -3
0
20
40
60
80
100
d) Octanol
pe
ak
 c
ur
re
n
ts
 
(%
)
-7 -6 -5 -4
0
20
40
60
80
100
e) Decanol
-8 -7 -6 -5
0
20
40
60
80
100
f) Dodecanol
Log [drug] (M)
pe
ak
 c
ur
re
n
ts
 (%
)
-8 -7 -6 -5
0
20
40
60
80
100
g) Tetradecanol
Log [drug] (M)
Fig. 2.Concentration-response curves for long-chain n-alkanols become insensitive for short applications comparedwith long applications. Inhibition by n-alkanols of the peak amplitudes
of 5-HT (30 μM)-induced currents in open-channel and steady-state applications, normalized to the respective control currents in the absence of drug. The curves have been ﬁtted to Hill
equations (ﬁt parameters in Table 1). At thehighest concentration achievable for n-tetradecanol, suppression in the standard (1min) steady-state applicationwas less than 50% but not yet
complete (ﬁlled circle, n = 18 patches, signiﬁcantly different from control). Therefore, the wash-in time was increased to 4 min (open circle, n = 18 patches, signiﬁcantly different from
control and from the 1 min data point) when the suppression appeared complete (see text); note the large standard deviation.
Table 1
IC50 values and Hill coefﬁcients nH for brief and long applications of n-alkanols.
n-Alkanol Molecular formula IC50steady-state (M) nH IC50open-channel (M) nH
Ethanol C2H5OH 1.1 ± 0.25 −2.0 ± 1.1 1.7 ± 0.64 −1.4 ± 0.6
Butanol C4H9OH 3.0 ∗ 10−2 ± 7.8 ∗ 10−3 −1.2 ± 0.4 8.8 ∗ 10−2 ± 1.8 ∗ 10−2 −2.1 ± 0.8
Hexanol C6H13OH 1.5 ∗ 10−3 ± 2.0 ∗ 10−4 −2.8 ± 0.8 1.7 ∗ 10−3 ± 2.3 ∗ 10−4 −1.7 ± 0.6
Octanol C8H17OH 7.0 ∗ 10−5 ± 1.3 ∗ 10−5 −1.4 ± 0.3 1.4 ∗ 10−4 ± 6.2 ∗ 10−5 −0.9 ± 0.5
Decanol C10H21OH 2.5 ∗ 10−6 ± 3.6 ∗ 10−7 −1.5 ± 0.4 5.6 ∗ 10−5 ± 4.8 ∗ 10−5 (3 ∗ 10−5) −0.6 ± 0.2
Dodecanol C12H25OH 8.3 ∗ 10−7 ± 3.4 ∗ 10−7 −0.9 ± 0.4 (1 ∗ 10−6) /
Aqueous IC50 values and Hill coefﬁcients, nH, were obtained from ﬁtting the concentration-response curves in Fig. 2 to Hill equations (±95% conﬁdence intervals). Values in parentheses
represent, respectively, the highest experimentally employed concentrations (but at which the effects were still less than 50% in the open channel application).
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Table 2
Absolute potencies P50 and corresponding free energy changes for interactions of n-alkanols with 5-HT3A receptors.
n-Alkanol or phenol P50 (atm) Δμθ,drug− Δμθ,xenon (kJ mol−1) Water/gas partition coefﬁcient Aqueous solubility (M)
Ethanol 5.8 ∗ 10−3 −10.8 4680 2.2 ∗ 101
Butanol 2.5 ∗ 10−4 −17.3 2880 8.5 ∗ 10−1
Hexanol 2.2 ∗ 10−5 −23.8 1700 5.8 ∗ 10−2
Phenol 5.5 ∗ 10−7 −33.1 70,800 8.8 ∗ 10−1
Octanol 1.7 ∗ 10−6 −30.4 1000 4.2 ∗ 10−3
Decanol 1.3 ∗ 10−7 −36.9 468 2.3 ∗ 10−4
Dodecanol 1.0 ∗ 10−7 −37.3 204 2.2 ∗ 10−5
Propofol 3.8 ∗ 10−8 −39.7 11,500 7.0 ∗ 10−4
P50, were calculated from the IC50 [Table 1, phenol and propofol from a previous publication [4]] by using the water/gas partition coefﬁcients in column 4 for n-alkanols and phenol [16],
and for propofol calculated from Henry's Law Constant [17]. The water/gas partition coefﬁcient for n-dodecanol was extrapolated from n-decanol, using the ratio of n-nonanol
and n-decanol [16]. Free energy changes for a substance are expressed relative to the inert gas xenon and were calculated from P50 values (for n-alkanols obtained from the correlation
in Fig. 3; for xenon from [18]), see Eq. ((4) in Materials and methods. A tenfold potency change corresponds to a free energy change of 5.7 kJ mol−1. Aqueous solubilities were
taken from [17].
1530 A.-M. Decker et al. / Biochimica et Biophysica Acta 1848 (2015) 1524–1535preceding (unrestricted) curveﬁts to strongly depend on the chain
length of the n-alkanol (Table 3; see Discussion). In the extreme case,
all fast time constants and,with a different value, all slow time constants
could be identical for the different n-alkanols.
In order to test whether the present data are compatible with such a
hypothesis, the wash-in data were reﬁtted (Fig. 5f) by restricting free
parameters, with all n-alkanols sharing the same fast time constant
and the same slow time constant, respectively. Now there were only
two unrestricted parameters for each n-alkanol left (see Materials and
methods), yet despite these limitations the resulting (restricted)
curveﬁts (dotted lines in Fig. 5a–e, and Table 3) did not deviate much
from the unrestricted ﬁts (solid lines in Fig. 5a–e, and Table 3) with
only slightly deteriorated values for R2. However, the conﬁdence inter-
vals of the two time constants have become sufﬁciently narrow to indi-
cate that they are signiﬁcantly different by a factor of about seventy.
Furthermore, except for n-dodecanol, all the fast time constants of the
unrestricted ﬁts (Table 3) lie within or close to the conﬁdence interval
of this time constant for the restricted ﬁt (Table 3). Again, the fast
time constant (24 ms) of the restricted ﬁt did not exceed the resolution
limit of 52ms for thewash-in, and even its upper limit of the conﬁdence
interval remained close to 52 ms. Except for n-hexanol, the slow time
constants of the unrestricted ﬁt (Table 3) are also close to the conﬁ-
dence interval for that time constant of the restricted ﬁt (Table 3).
The slow time constant of the restricted ﬁt, estimated to be 1.7 s,
conﬁrms the previous analysis that the time constants of fast and slow
inhibition are separated by almost two orders of magnitude on the
time axis, consistent with the hypothesis that there are two distinct
processes of wash-in.
Returning to the issue of n-hexanol data points demonstrating
signiﬁcant potentiation (see Fig. 5b), the two different ways of curve
ﬁtting each reproduced this potentiation (see below). Furthermore,0 2 4 6 8 10 12
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Fig. 3. Free energy change per methylene group of n-alkanols. The logarithms of the mole
fractions xgas,50% of n-alkanols required to suppress the peak of the 5-HT3A receptor
current by 50% are plotted versus the number of methylene groups in the molecule
(not the number of carbon atoms). The linear regression shown yields a free energy
change per methylene group of −3.27 kJ mol−1, where r2 = 0.998; the n-dodecanol
point has not been included in the regression calculation.when individual patches exposed to n-hexanol were considered, they
each showed this potentiating component beyond 1 s wash-in duration
aswell (data not shown). Normally, however, individual patches did not
all last long enough to contain all the time points of a wash-in curve for
any of the n-alkanols shown in Fig. 5. Nevertheless, four out of eight
patches contributing to the wash-in curve for n-hexanol (Fig. 5b) had
a sufﬁcient number of data points so they could be ﬁtted individually,
each patch exhibiting a potentiation with a similar time course as that
shown in Fig. 5b. Slow inhibition by n-hexanol could not be detected
and if present would be masked by a dominating potentiation with a
similar time course (Fig. 5b).
Saturating concentrations of n-tetradecanol produced signiﬁcant
inhibition after wash-in for oneminute (Figs. 1 and 2). However, inhibi-
tion became signiﬁcantly stronger when the wash-in time was in-
creased from one minute (32 ± 25% , n = 18 patches) to four minutes
(64 ± 35% , n = 18), suggesting wash-in time constants of the order
of one minute or more. The determination of such long time constants
proved experimentally more difﬁcult, at least partly because of a
large variability such as is indicated by the large standard variations
above. However, rundown was not accelerated in the presence of
n-tetradecanol (7.9 ± 3.0 min, n = 10 patches compared with 9.1 ±
3.8 min, n = 6 patches in the absence of n-tetradecanol; each patch
lasting longer than two times the rundown time constant), suggesting
that the variability did not originate from an increase of irreversible
effects (such as rundown) on the current amplitude.
While our wash-in data showed potentiation caused by n-hexanol,
only indirect evidence of a similar potentiation was detectable for
wash-in of n-butanol (see Discussion). However, potentiation has
been described for n-alkanols below n-hexanol in whole cell experi-
ments [12,13], where amplitudes of currents elicited by low 5-HT
concentrations were increased by n-alkanols. Therefore, we examined
the effects of n-butanol in outside-out patches on currents elicited by
low 5-HT concentrations.
The two series of currents shown in Fig. 6a and b correspond to the
same patch but recorded at different lifetimes of the patch. This appar-
ently had an impact on how potentiation of the current amplitude was
observed. While the amplitudes of currents induced by our standard
concentration of 30 μM 5-HT were still reduced in the presence of
20 mM n-butanol, consistent with our other data (Figs. 1 and 2),
currents induced by 1 μM or 2 μM 5-HT could be potentiated (Fig. 6).
In this example, typical of other patches as well, currents recorded
from the patch did not show potentiation of the maximal peak initially
(Fig. 6a), but did so 16 min later (Fig. 6b). It should be noted that all
traces in this ﬁgure were recorded from the same patch, and that they
do not show an arbitrary variability but a systematic progression in
their behavior, with the data at 1 μM 5-HT supporting those recorded
at 2 μM 5-HT.
This observation may be related to the fact that the kinetics (τrise
and τdecay) of 5-HT induced control currents had accelerated in this
patch, common for 5-HT induced currents recorded from a patch as it
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Fig. 4. Current kinetics are accelerated by n-alkanols for both applications. n-Alkanol concentrations were close to their respective IC50steady-state value. For each patch, the time constant
of current onset (τrise) or current decay (τdecay) during drug application was normalized by the respective time constant for the control current (control: τrise = 9.4 ± 8.2 ms, 111
measurements in 51patches; τdecay=114.7±102.5ms, 110measurements in 51patches). All data are signiﬁcantly different from100% (paired Students t test), except for τrise for ethanol
(both applications) and τrise (open-channel application) for n-butanol and for n-dodecanol.
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Fig. 5. Biphasic kinetics of n-alkanol actions. The peak current (normalized to control beforewash-in) remaining afterwash-in of the n-alkanol (at a concentration close to the IC50steady-state)
is plotted versus wash-in duration. Note that for n-hexanol (Fig. 5b), an initial inhibition of peak amplitude is followed by a second process of potentiation, leading to a partial recovery
(see text); the asterisk denotes that the difference between the two indicated data points (before begin and after completion of potentiation) is signiﬁcant (unpaired t test); the ﬁrst point
was chosen because the fast processwas complete and the second process had not begun yet; the second point was chosen after the second processwas complete and a plateau had been
reached again. Each curve represents between 5–10 patches. Parameters of the ﬁtted curves (solid lines: each n-alkanol ﬁtted by their own set of parameters; dotted lines: all n-alkanols
share the same two time constants; see Materials and methods) are given in Table 3. Experimental data and the ﬁts (shared time constants) for all n-alkanols (from Fig. 5a–e) are
superimposed in the last subﬁgure (Fig. 5f).
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Table 3
Kinetic parameters for the biphasic wash-in of n-alkanol actions.
n-Alkanol
parameters:
Conﬁdence interval:
Conﬁdence interval:
τfast (ms)
Free/shared
Free parameters
Shared parameters
Ffast (%)
Free/shared
Free parameters
Shared parameters
τslow (s)
Free/shared
Free parameters
Shared parameters
Plateau (%)
Free/shared
Free parameters
Shared parameters
R2
Free/shared
Butanol 16/24
(–)
(14–71)
40/38
(29–52)
(27–48)
4.1/1.7
(2.2–24.5)
(1.2–2.7)
38/40
(34–43)
(36–44)
0.74/0.71
Hexanol 21/24
(11–260)
(14–71)
137/134
(115–158)
(111–157)
11.6/1.7
(–)
(1.2–2.7)
56/53
(50–62)
(48–58)
0.38/0.31
Octanol 5/24
(–)
(14–71)
67/77
(47–88)
(62–92)
0.48/1.7
(–)
(1.2–2.7)
38/38
(34–42)
(32–43)
0.51/0.47
Decanol 34/24
(–)
(14–71)
31/35
(6–56)
(23–46)
0.99/1.7
(0.56–4.69)
(1.2–2.7)
37/36
(32–42)
(30–41)
0.83/0.81
Dodecanol 830/24
(–)
(14–71)
64/0
(0–100)
(0–10)
4.8/1.7
(–)
(1.2–2.7)
49/50
(43–56)
(45–54)
0.72/0.71
Fit parameters for the two types of ﬁts, both of which ﬁt the biphasic data shown in Fig. 5. Data are displayed as indicated in the header row. Fast and slow time constantswere determined
either as free parameters (independent for each n-alkanol) or as shared parameters (each n-alkanol has the same fast and the same slow time constant; seeMaterials andmethods). Their
95% conﬁdence intervals are given in the two rows below; (–) indicates that no conﬁdence interval could bedetermined. Additional free parameterswere the fraction of the fast effect (Ffast,
percentage of the total effect) fromwhich the fraction of the slow effect can be calculated (Fslow= 100%− Ffast), and the value for the plateau current left after thewash-in was complete.
The fraction of the slow effect for n-hexanol is negative since it represents a potentiation. Values for R2 are also shown (seeMaterials andmethods). Note that the conﬁdence intervals for
the shared time constants have become very narrow comparedwith those for the free time constants, supporting the conclusion that the fast and slow time constants ofwash-in differ by a
factor of about seventy for all n-alkanols. The other conﬁdence intervals (for Ffast or plateau) have mostly changed comparatively little between the two different types of ﬁt.
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currents can inﬂuence the observed pharmacological response. The
test of this hypothesis requires grouping currents according to the
kinetics of their control currents and then averaging the observed
pharmacological response of these groups. Although we regularly had-500pA
500ms
5-HT (1 µM)
5-HT(30 µM)
5-HT (2 µM)
a)
-100pA
500ms
5-HT control current
open-channel
5-HT (1 µM)
5-HT(30 µM)
5-HT (2 µM)
b)
Fig. 6. Example of potentiation at low [5-HT]. Currentsmay ormay not show potentiation,
in this case by 20mMn-butanol (open-channel application), depending on [5-HT] and on
current kinetics. In Fig. 6a n-butanol (blue trace) potentiates at 1 μM5-HT but potentiation
is not as clear cut at 2 μM 5-HT. Although the current rises sooner and the peak (2 μM
5-HT) is reached earlier (blue trace, its maximal amplitude is about the same as for the
control current (black)). The traces of Fig. 6b have been recorded 16 min later. The
respective control currents have become faster than in Fig. 6a (current kinetics tend to
accelerate during the lifetime of a patch) and now both currents appear potentiated at
both low 5-HT concentrations (1 and 2 μM). The current at 30 μM 5-HT remains still
suppressed by n-butanol though this is not shown in this particular ﬁgure (compare also
Fig. 1b) because, in order to increase resolution, currents in Fig. 6b were recorded at a gain
where the peak of the 30 μM5-HT-induced current saturated (indicated by the double slash).patches that were potentiated and others that were not, these experi-
ments were not pursued in this paper, because of the large number of
patches needed to reach statistical signiﬁcance because of the small
currents involved. However, similar observations were made with n-
hexanol and n-octanol (but not with ethanol), strengthening the
hypothesis.4. Discussion
4.1. Alkanols still show many interactions
Reviewing the experimental results reveals that the actions of the
n-alkanols are not much simpler than those of propofol and the phenol
derivatives [4]. n-Alkanols affect different current parameters simulta-
neously, such as amplitude (Figs. 1 and 2, Table 1) as well as onset
and decay time constants and their fractional effects (Figs. 1 and 4) in
such a way that none is identical to any other in all their actions.
Being able to separate drug effects that would normally appear
superimposed (Fig. 5), it became possible to distinguish fast and slow
inhibitory as well as potentiating effects.
In the nicotinic acetylcholine receptor, which is closely related to
the 5-HT3 receptor, at least three different mechanisms of action of
n-alkanols have been suggested, comprising the channel lumen, an allo-
steric site on the protein, and a site involving either themembrane lipid
or the lipid/protein interface [23]. However, their relative contributions
have not been quantitated. Attempts to quantitatively pry apart differ-
ent mechanisms for 5-HT3 receptors have also been hampered because
of incomplete or even contradictory experimental data. An impractical
large number of experiments would be required in order to prove
with statistical signiﬁcance that three or even more (ever smaller)
superimposing effects are independent. This is suggested from the
experience of other experiments involving the separation of only two
effects, where evidence had been presented that fast and slow inhibito-
ry actions on 5-HT3 receptor appear to be independent and additive for
propofol and other phenol derivatives [4] as well as for ifenprodil [24].
Lack of experimental data has to be considered also in the context of
the mathematical model that has been suggested for 5-HT3A receptors.
In its reduced form it still has eight free parameters, more than can be
determined experimentally [25].
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amplitude potentiation for n-hexanol was observed in N1E 115 whole
cells [13] it was not detected in Xenopus oocytes [26]. Furthermore,
the amplitude potentiation for short-chain n-alkanols observed in
Xenopus oocytes preparation [26] is much larger than that reported in
a whole cell preparation [13], and it is even smaller in the excised
outside-out patch study presented here. Inconsistent results from
different experimental approaches may be partly a methodological
problem related to time resolution: the IC50 of the inhibitory action of
morphine on 5-HT3A receptors differed by a factor of more than three
when measured within the same laboratory in either the whole cell
mode [27] or in the excised outside-out patch mode [28]. Similarly,
competitive action of metoclopramide at 5-HT3A receptors was detect-
able in (slow) radioligand binding studies but not in (fast) excised
outside-out patches [19]. In this context, differences in the kinetics of
control currents as illustrated by exemplary n-butanol experiments
(Fig. 6) may determine how potentiation in current amplitude at low
5-HT concentrations is detected, suggesting the hypothesis that the ki-
netics of control currents can inﬂuence the observed pharmacological
response.
Particularly when processes have similar kinetics it becomes even
more difﬁcult to separate them, such as a superposition of fast inhibition
and a postulated fast potentiation for n-butanol as suggested in the
following. It has been observed above that n-butanol does not quite ﬁt
the trend in the progression from short-chain to long-chain n-alkanols
(Figs. 1, 2 and 5). Here the fast inhibitory component is less pronounced
than for ethanol, n-hexanol or n-octanol, perhaps because it may
be offset by an additional component of potentiation, similar to the
one detected for n-hexanol, but faster. Therefore, the fast inhibitory
component may appear less pronounced for n-butanol (Fig. 5a) than
for n-hexanol (Fig. 5b) because it simply reﬂects a superposition of
independent processes of potentiation and fast inhibition such that
inhibition dominates. The future comparison of different but related
homologues may help to support or discard this hypothesis.
Trying to characterize individual molecular actions underlying the
observed effects becomes all the more difﬁcult the more other con-
founding effects and actions there are. Therefore, the strategy has
been adopted instead to ﬁrst compare both the overall and the distinct
effects of drugs possessing different chemical functional groups, but
using the same methodology throughout. Having identiﬁed chemical
groups that are associated with distinct functional effects might then
help in the future to study different functional effects in isolation.
4.2. Absolute potencies and free energies
Despite their many actions the overall effect of n-alkanols on the
peak of the 5-HT-induced current is inhibition (Fig. 2). The potency
for inhibition increases with the chain length of the n-alkanol
(Tables 1 and 4). Thus each methylene group added to an n-alkanol
causes it to interact more strongly with its target(s). The chain length
dependence of the IC50steady-state values (Table 1) yields a free energy
change of −3.97 kJ mol−1 per methylene group from the aqueous
phase to the site of anesthetic action, whereas the free energy change
per methylene group from the gas phase to the site of anesthetic action
is−3.27 kJ mol−1 (Fig. 3). These values are typical for free energies of
transferring methylene groups of n-alkanols into lipid bilayers or
hydrocarbon/aqueous interfaces [15]. There are two noteworthy
results: ﬁrst, the main contribution to the free energy of transfer
stems from the interaction of the methylene with anesthetic sites
(−3.27 kJ mol−1) and not from leaving the aqueous environment
(−0.70 kJ mol−1). Thus van der Waals forces appear to be much
more important in this interaction than hydrophobic forces. This was
already indicated by the fact that the water–gas partition coefﬁcients
for n-alkanols were much less chain length dependent than the poten-
cies at the 5-HT3A receptor (Table 2): whereas the partition coefﬁcient
decreases bymerely a factor of ten between ethanol and n-decanol, thecorresponding IC50steady-state value decreases by more than ﬁve orders of
magnitude. Second, the methylene groups interact more strongly (by
−0.93 kJ mol−1) with the ligand-gated 5-HT3A receptor than with a
voltage-gated sodium channel [15]. If this result is conﬁrmed for other
ion channels as well, then the 2.1-fold potency difference observed
between voltage-gated and ligand-gated ion channels for volatile anes-
thetics [1] may in part (factor of 1.4) result from methylene groups
interacting more strongly with ligand-gated ion channels. By consider-
ing and comparing other homologous series, estimates of free energies
for other chemical functional groups may be obtained.
4.3. Cutoff
Using an excised outside-out membrane preparation in conjunction
with a fast solution exchange system resulted in two wash-in time con-
stants that varied little (less than a factor of ten, for the unrestricted ﬁt,
and less than a factor of three, for the restricted ﬁt, as suggested by the
conﬁdence intervals in Table 3) between different n-alkanols until and
including n-decanol (Table 3 and related text), suggesting that the
values of these time constants are not dependent on ﬁlling a lipophilic
site in equilibrium with the anesthetic site of action. If the time con-
stants reﬂected simple binding then they would be expected to be
roughly inversely proportional to the concentration at which they
were recorded [29], thus being of the order of 30when two neighboring
n-alkanols are compared or by a factor of 90,000 between n-butanol and
n-dodecanol. Thus wash-in time constants that vary little between
different n-alkanols suggest that they are determined by transitions
between conformational states (such as resting as well as fast and
slow desensitized states) rather than by binding reactions.
However, loss of inhibitory potency was pronounced beyond
n-dodecanol, although some inhibitory activity was still observed for
n-tetradecanol by us (Figs. 1 and 2, but note the much higher concen-
tration by comparison) and others [13]. The overall trend in the pro-
gression from short-chain to long-chain n-alkanols was the fading
contribution of the fast inhibitory component (Table 3), so that for n-
dodecanol nomore fast inhibition was detectable. The fading of one in-
hibitory component while another remained had been observed before
for potassium channels in the same membrane where no such fading
had been observed for simultaneously present sodium channels, thus
ruling out the n-alkanol not adequately reaching its site of action [22].
Do these ﬁndings imply that two different binding pockets or inter-
action sites of limited molecular dimensions are responsible for fast
and slow inhibitory processes? To complicate matters further, the sig-
niﬁcant acceleration of the decay time constant (Fig. 4) suggests
that some fast action of n-dodecanol still remains. Furthermore, the
concept of binding pockets of limited dimensions becomes even more
problematic as molecular size cannot be the exclusive reason for
long-chain n-alkanols losing their inhibitory potency [30]: Anandamide
(N-arachidonoylethanolamine), a linear molecule consisting of 22
carbon atoms and terminated, as the n-alkanols are, by a hydroxyl
group is still capable of inhibiting 5-HT3A receptors [31], although it is
almost twice the size of n-dodecanol. Possessing additional polar
(amide) groups and four double bonds make it much more water solu-
ble. Similarly, propofol in contrast to n-dodecanol (both containing
12 carbons) still retains fast inhibitory action on current amplitude.
In this context it may be relevant that propofol also is more water
soluble than n-dodecanol (Table 2). Furthermore, the n-alkanols
cut off at n-tetradecanol, the alkenols at octadecenol, the n-alkanes at
n-decane, and the perﬂuoroalkanes at butane [30], correlating well
with their respective aqueous solubilities. The same is found when the
cutoff is compared between n-alkanols and cycloalkanemethanols
[32]. In addition, the large variability observed in the data in the
presence of n-tetradecanol (see Results) must also be considered. It is
well known that long-chain n-alkanols are difﬁcult to work with
because they adhere to the apparatus and signiﬁcant quantities may
partition into membranes [33]. Despite the use of the fast superfusion
1534 A.-M. Decker et al. / Biochimica et Biophysica Acta 1848 (2015) 1524–1535system, therefore, it is possible that some not yet fully understood
artifact(s) based onmacroscopic properties of n-alkanols, such as aque-
ous solubility or adsorption to interfaces, may be responsible for
observed cutoffs in inhibition rather than their molecular interaction
with protein sites of limited dimensions.
This should be less of a problem for cutoff in potentiation. However,
while there is agreement that cutoff for potentiation occurs at lower
chain-length of n-alkanols, there is disagreement as to where this
should be. Whole cell recordings from 5-HT3 receptors in N1E-115 re-
port n-hexanol potentiating current amplitude [13], but potentiation
by n-hexanol or higher n-alkanols was neither detected in 5-HT3A
receptors [12] nor in 5-HT3(A + B) receptors expressed in Xenopus
oocytes [26]. We have detected evidence of potentiation for n-hexanol
(Fig. 5b) and, at low 5-HT concentration, also for n-butanol (Fig. 6) in
some patches. Furthermore, analogous to some of the other examples
we have discussed before, potentiation may still be present even for
larger homologues but bemasked because of a simultaneous superposi-
tion by a larger inhibitory process. Thus potentiation observed in
excised outside-out patches has always been small at best, despite the
much better kinetic resolution than that obtainable in whole cell
measurements. This together with the already discussed differences in
kinetic resolution or even in functional endpoints deﬁning potentiation
contributes to the uncertainty in determining cutoff points for
potentiation.
Obviously the conclusions on cutoff points are not clear cut. There
may be in principle at least three cutoff points if we add the cutoff
in fast inhibition to those for inhibition and potentiation previously
proposed for 5-HT3 receptors [13]. The implications for molecular inter-
action sites, however, remain very unclear. Not only may macroscopic
effects cause distortions but it has also been argued before that consid-
ering cutoff in function only without complementary binding measure-
ments was an untenable approach for mapping binding site sterics [34].
4.4. Comparison between n-alkanols and some phenol derivatives
n-Alkanols (Table 1) and the phenol derivatives [4] have in common
that the overall effect is current inhibition and that during wash-in at
least two componentswith distinct time constants separated by approx-
imately two orders of magnitude (Table 3) can be distinguished and are
similar to those for propofol (35 ms and 4.8 s, [4]). However, while for
the n-alkanols both processes are inhibitory except for n-hexanol
(where the slower process is potentiating), only propofol showed two
inhibitory processes, while phenol and 2-isopropylphenol caused fast
amplitude potentiation, followed by a slower inhibitory component.
For both propofol and n-alkanols, the acceleration of the decay
(τdecay) time constant of the 5-HT-induced current washes in very fast
and is present in the open-channel application already. n-Alkanols and
propofol [4] also have in common that the concentration-response
curves for slow inhibition of the current amplitude are more potent
than the corresponding curves for the fast inhibition (Table 1).
However, there was no evidence of strong potentiation as observed
for 2-isopropylphenol and phenol [4] that remains detectable in the
steady-state application. These phenol derivatives caused pronounced
amplitude potentiation even at 30 μM 5-HT and substantially slowed
the time constant of current decay also in the steady-state application.
In contrast, none of the n-alkanols slowed the decay time constant or
potentiated the amplitude of currents induced by high concentrations
of 5-HT (30 μM). Instead, decay time constants were generally acceler-
ated (Fig. 4). Fig. 6 provided an example of current kinetics apparently
determining whether or not amplitude potentiation is observed. This
raises the question whether differences in current kinetics (whole cell
patches feature currents that are of the order of 50 times slower than
those of excised patches, and currents recorded from Xenopus oocytes
are even slower)may be the reasonwhyatmost amplitude potentiation
seen in our experiments is weak while in whole cell recordings larger
potentiation has been observed [12,13,26].Another example of weak potentiation is the slow potentiation that
follows a fast inhibition by n-hexanol (Fig. 5b). These two processes
superimpose so that the total effect under equilibrium conditions is
inhibition. This type of slow potentiation was not detected for other
n-alkanols. It may have been present but masked by a stronger slow in-
hibition. Separation becomes difﬁcult because the relative contribution
of all components to the overall effect depends on drug concentration
and exposure time as well as on the chain-length of the n-alkanol
(Figs. 4 and 5, Table 3).
The reason for the absence of strong potentiation in n-alkanols may
be that the phenolic hydroxyl group is able to form stronger hydrogen
bonds than the n-alkanolic hydroxyl group, consistent with previous
observations that potentiation of 5-HT currents was much stronger for
trichloroethanol than for ethanol [35], the former also being capable
of forming stronger hydrogen bonds than the latter.
Both phenol and n-hexanol each possess six carbon atoms and a
hydroxyl group but differ in the aromatic ring structure of the phenol.
Similarly, propofol and n-dodecanol also correspond to each other,
possessing twelve carbon atoms and a hydroxyl group each. However,
whereas the potency (referred to the gas phase) increases with chain
length between n-hexanol and n-dodecanol by a factor of 220, it
increases by only a factor of 42 between phenol and propofol. Electro-
negativity of and steric hindrance by the two isopropyl groups on either
side of the phenolic hydroxyl group may be responsible. This is consis-
tent with earlier reports of a reduced potency of propofol [4]. If this re-
duced reactivity (relative to other phenol derivatives) between propofol
and 5-HT3 receptors is also characteristic of its interactions with anes-
thetic sites considered important for anesthesia (e.g. GABAA receptors),
it could imply that in clinical use propofol has fewer side effects than
other phenol derivatives. This may have been one of the reasons why
it has been found superior to more than ﬁfty other phenol derivatives
during in vivo testing [36].
5. Conclusions and outlook
In conclusion, when the structurally simpler n-alkanols are com-
pared with propofol and related phenol derivatives much of the com-
plexity of modulation of function by these drugs is retained. Each of
these alcohols and phenols possess partly similar but overall distinct
spectra of effects, none of them is identical to any other of these drugs
in all its actions. The aqueous potency increase per methylene group
of the n-alkanol is due mainly to interactions of the methylene group
with its anesthetic target and to a lesser extent due to its partitioning
out of the aqueous phase because of its hydrophobicity. Absolute inter-
action energies (relative to xenon) increased from−10.8 kJ mol−1 for
ethanol to−37.3 kJ mol−1 for n-dodecanol.
Potentiation by the n-alkanols isweaker than that by phenol, consis-
tent with the less reactive hydroxyl group of n-alkanols suspected to
play a role in this interaction. Different cutoffs in function have been
detected but their molecular interpretation remains uncertain. Propofol
is less potent relative to other related phenol derivatives when com-
pared with the series of n-alkanols. Wash-in time constants that vary
little between different n-alkanols suggest that they are determined
by transitions between conformational states rather than by binding
reactions. Further studies with other series of homologues possessing
weaker or no polar groups are needed in order to conﬁrm these conclu-
sions, to identify the origin of the two time constants, to characterize the
role of the hydroxyl group in inhibition and potentiation, and to further
explore the nature of cutoff in potency.
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